QVP
- Product code
- QVP
- Device name
- Sars-Cov-2 Serology Test
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3983
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 5 (all years; only the last 3 years are listed here)
FDA classification definition
A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K252280 | 2026-04-13 | Roche Diagnostics | Elecsys Anti-SARS-CoV-2 S | |
| K253839 | 2025-12-17 | Roche Diagnostics | Elecsys Anti-SARS-CoV-2 | |
| K250768 | 2025-06-10 | Roche Diagnostics | Elecsys Anti-SARS-CoV-2 |
Official FDA classification page: QVP
Classification and pathway per current FDA publications. Data from openFDA (CC0).